RxWires

Company

Aurobindo

Aurobindo has 31 drugs tracked on RxWires: 27 approved, 3 in Phase 3, 1 in Phase 1.

Pipeline

DrugPhaseIndication
DROSPIRENONE AND ETHINYL ESTRADIOLApproved
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUSApproved
SAPROPTERIN DIHYDROCHLORIDEApproved
NEVIRAPINEApproved
ERYTHROMYCIN ETHYLSUCCINATEApproved
VENLAFAXINEApproved
SILDENAFIL CITRATEApproved
TARINA 24 FEApproved
SPIRONOLACTONEApproved
CIMETIDINEApproved
METFORMIN HYDROCHLORIDEApproved
LIDOCAINEApproved
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDEApproved
MEMANTINE HYDROCHLORIDEApproved
ESCITALOPRAMApproved
VALSARTANApproved
MODAFINILApproved
CANAGLIFLOZINApproved
TRAZODONE HYDROCHLORIDEApproved
REPAGLINIDEApproved
FLECAINIDE ACETATEApproved
PSEUDOEPHEDRINE HYDROCHLORIDEApproved
MONTELUKAST SODIUMApproved
POSACONAZOLEApproved
LORAZEPAMApproved
FLUCONAZOLEApproved
ACYCLOVIRApproved
Adapalene 0.1% GelPhase 3Acne Vulgaris
Methacholine ChloridePhase 3Bronchial Asthma
Test ProductPhase 3Bronchial Asthma
Amphotericin B LiposomePhase 1Visceral Leishmaniasis

Latest

Follow Aurobindo on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.

Follow free

Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.